Reports on the development of a ribozyme therapeutic by Boulder, Colorado-based Ribozyme Pharmaceuticals Inc. and Indianapolis, Indiana-based Eli Lilly Co. to treat hepatitis C virus. Amount that Ribozyme will receive for development; Ribozyme on which the therapeutic is based.